Metformin exposure after glioblastoma diagnosis and mortality: A large population-based study
{{output}}
Background: Glioblastoma (GBM) is an aggressive primary brain malignancy with limited therapeutic options and poor survival outcomes. Recent real-world studies and early-phase clinical trials evaluating metformin have yielded mix... ...
